Evidence map›Paper›PMID 26967640›Full record

ArticlePloS one2016

Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells.

Jihye Kim, Kyung Jin Lee, Jung Seok Kim, Jun Gi Rho, Jung Jae Shin, Woo Keun Song, Eun Kyung Lee, Josephine M Egan, Wook Kim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Metabolic Consequences of Gestational Cannabinoid Exposure.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Jihye KimDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Kyung Jin LeeDepartment of Convergence Medicine, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, Korea.
Jung Seok KimDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Jun Gi RhoDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Jung Jae ShinDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Woo Keun SongDepartment of Life Science, Bio Imaging and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju, 61005, South Korea.
Eun Kyung LeeDepartment of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea.
Josephine M EganLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, United States of America.
Wook KimDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, South Korea.
Ajou University · KRCatholic University of Korea · KRGwangju Institute of Science and Technology · KRNational Institute on Aging · USUlsan College · KR

Funding

Drug Development of GLP-1 receptor agonistsZIAAG000905 · NIA · NATIONAL INSTITUTE ON AGING · PI EARLEY, JOSEPHINE · 2009 to 2019
$4.6M
The endogenous cannabinoid system and glucose homeostasisZIAAG000960 · NIA · NATIONAL INSTITUTE ON AGING · PI CHIA, CHEE W · 2009 to 2025
$4.1M
Intramural NIH HHS
6 · The paper itself

Abstract

Recent reports have shown that cannabinoid 1 receptors (CB1Rs) are expressed in pancreatic β cells, where they induce cell death and cell cycle arrest by directly inhibiting insulin receptor activation. Here, we report that CB1Rs regulate the expression of the anti-apoptotic protein Bcl-2 and cell cycle regulator cyclin D2 in pancreatic β cells. Treatment of MIN6 and βTC6 cells with a synthetic CB1R agonist, WIN55,212-2, led to a decrease in the expression of Bcl-2 and cyclin D2, in turn inducing cell cycle arrest in G0/G1 phase and caspase-3-dependent apoptosis. Additionally, genetic deletion and pharmacological blockade of CB1Rs after injury in mice led to increased levels of Bcl-2 and cyclin D2 in pancreatic β cells. These findings provide evidence for the involvement of Bcl-2 and cyclin D2 mediated by CB1Rs in the regulation of β-cell survival and growth, and will serve as a basis for developing new therapeutic interventions to enhance β-cell function and growth in diabetes.

Indexed as

AnimalsApoptosisCannabinoidsCell Cycle CheckpointsCell LineCell ProliferationCyclin D2Flow CytometryGene Expression RegulationInsulin-Secreting CellsMiceMice, Inbred C57BLProto-Oncogene Proteins c-bcl-2Receptor, Cannabinoid, CB1CannabinoidsCcnd2 protein, mouseCyclin D2Proto-Oncogene Proteins c-bcl-2Receptor, Cannabinoid, CB1

Identifiers

PMID26967640
PMCPMC4788443
OpenAlexW2295564407

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.